Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| select non-sterile manufacturing assets at Dechra’s Pomona, California manufacturing | Bimeda | Veterinary Drugs | $18.0M – $24.0M | 6× – 8× | |
| selected non-sterile manufacturing assets of Dechra in Pomona, California | bimeda | Veterinary Drugs | $19,000M | 9× – 12× | |
| Animalcare Group | Charterhouse Capital Partners | Veterinary Drugs | $190M – $257M | 10× – 14× | |
| MYOS Corp | PetIQ | Veterinary Drugs | $2,482M – $3,358M | 12× – 16× | |
| Thyronorm | Undisclosed | Veterinary Drugs | $1,724M – $2,332M | 11× – 14× | |
| SOMA LABS | Icelandirect, New Heritage Capital | Veterinary Drugs | $39.0M – $46.0M | 8× – 9× | |
| Thyronorm | Virbac | Veterinary Drugs | $1,100M – $1,300M | 14× – 17× | |
| Covetrus, MWI Animal Health | Cencora | Veterinary Drugs | $3,500M | 11× – 13× | |
| Animalcare | Charterhouse | Veterinary Drugs | $270M | 11× – 13× | |
| Hyperdrug Pharmaceuticals | Vulcan Two Group PLC | Veterinary Drugs | $30.0M – $36.0M | 9× – 11× |
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.